Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
ANGELS Update Antidepressants in Pregnancy Linda L.M. Worley, MD, Associate Professor UAMS, Departments of Psychiatry & OB/GYN REVIEW: Untreated Depression in PG linked to increased risks for: • Miscarriage • Growth restriction (Teixeira et al 1999; British Medical Journal) • Poor prenatal care compliance & nutritional intake • Use of other drugs/smoking • Prematurity • Pre-eclampsia (Kurki et al 2000; Obstetrics and Gynecology) • Low APGAR scores REVIEW: Untreated Depression in PG linked to increased risks for: • Suicidal ideation & attempts (Einarson et al 2001; J Psychiatry Neurosci) • Postpartum depression (Post 1992; Am J Psychiatry) • Decreased success @ breastfeeding • Increased CRH & decreased fetal responses to a novel stimulus (Sandman et al 1999; Ann NY Acad Sciences) • Irritable & difficult to console infants Risks of exposure to antidepressants • Neonatal discontinuation syndrome (see next slide) “Poor Perinatal adaptation” “Serotonin overstimulation” (Laine et al 2003) (Chambers et al 1996) Myoclonus Tachypnea/ Restlessness respiratory Tremor distress/ Jitteriness desaturation on Shivering Hypofeeding Hyperreflexia thermia Hypoglycemia Nausea Poor tone Involuntary Weak/absent cry movements Rigidity Cautious approach • Informed consent: Risks & benefits of treatment versus not • Monitor neonate for withdrawal &/or toxicity from antidepressants for at least 48 hours after birth (Koren 2004; Arch Pediatr Adolesc Medicine) Potential Strategies to Manage Neonate To Decrease Risk for Toxicity: Taper/stop maternal drug prior to due date if risk of maternal illness doesn’t outweigh risk of complications To Decrease Risk for Withdrawal: Lactation may provide minimal additional dose to reduce rapid drug concentration drop